Heidi Hörig - Concepedia

Author

Heidi Hörig

Albert Einstein College of Medicine

Also Known As

H Hörig, H. Hörig, Heidi Horig, Heidi Hörig, Heidi Hörig

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Albert Einstein College of Medicine University of Basel Yeshiva University Columbia University Irving Medical Center Columbia University

About

Heidi Hörig is an author at Albert Einstein College of Medicine specializing in immunology, medicine, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	818
2	Allergy	2	2	56
3	Engineering	1	1	108
4	Natural Sciences	1	1	42
5	Biochemistry	1	1	42

Heidi Hörig

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule Heidi Hörig, David S. Lee, William R. Conkright, Cancer Immunology Immunotherapy VaccinationVaccine DevelopmentImmunologyVirologyVaccine Design	2000	207
Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes Greg A. Kicska, Long Li, Heidi Hörig, Proceedings of the National Academy of Sciences	2001	187
The lymphoid chemokine CCL21 costimulates naïve T cell expansion and Th1 polarization of non-regulatory CD4+ T cells Kenneth Flanagan, Dorota Moroziewicz, Heesun Kwak, Cellular Immunology Lymphoid Chemokine Ccl21T-regulatory CellImmunologyAutoimmunityT Cell Immunity	2004	138
Obstacles and opportunities in translational research Heidi Hörig, Elizabeth Marincola, Francesco M. Marincola Nature Medicine International ResearchEngineeringTranslational ScienceTranslational RelevanceTranslational Research	2005	108
Exogenous glutamine requirement is confined to late events of T cell activation Heidi Hörig, Giulio C. Spagnoli, Luis Filgueira, Journal of Cellular Biochemistry	1993	88
Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity Howard L. Kaufman, Ken Flanagan, Christopher S.D. Lee, Vaccine VaccinationVaccinia Virus ResultsImmunologyTherapeutic VaccineImmunologic Mechanism	2002	56
Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA Elisabeth Eppler, Heidi Hörig, Howard L. Kaufman, European Journal of Cancer Human Dendritic CellsImmunologyPathologyTherapeutic VaccineAntigen Processing	2002	55
From bench to clinic and back: Perspective on the 1st IQPC Translational Research conference Heidi Hörig, William E. Pullman Journal of Translational Medicine	2004	54
Poxviruses as vectors for cancer immunotherapy. Heesun Kwak, Heidi Hörig, Howard L. Kaufman PubMed VaccinationVaccine DevelopmentVaccine TargetImmunologyTumor Immunity	2003	52
Glutamine requirements in the generation of lymphokine-activated killer cells A. Juretić, Giulio C. Spagnoli, Heidi Hörig, Clinical Nutrition Autoimmune DiseaseGlutamine RequirementsImmunologyImmunologic MechanismAutoimmunity	1994	46

Page 1